Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.28% to 7,078.20.
The Pro Medicus Ltd (ASX:PME) share price is currently higher after the company held its AGM and gave some promising updates.
Here are 10 reasons why an investor would sell shares or ETFs.
The Pro Medicus Ltd (ASX: PME) share price has risen after revealing another solid contract win in Australia.
Can Pokemon cards be a good investment? On this episode of The Australian Investors Podcast, Owen Rask & Drew Meredith answer your questions.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.11% to 7030.30.
Pro Medicus Limited (ASX: PME) was a standout, adding 12.4%. The radiology imaging technology firm announced another $140 million ten year contract in the US as the business continues to scale quickly.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.45% to 7044.90.
The Pro Medicus Ltd (ASX:PME) share price is on watch after the healthcare imaging software ASX share announced a great win in Texas.